12:00 AM
 | 
Mar 22, 2010
 |  BC Week In Review  |  Company News  |  Deals

Medivir, Daewoong Pharmaceutical, Hainan Noken Pharmaceutical Industry deal

Daewoong assumed exclusive rights to develop and commercialize Medivir's MIV-210 (lagociclovir valactate) in South Korea, Japan and China from Hainan. Medivir retains rights elsewhere. The nucleoside analog prodrug...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >